Accessibility Menu
Surgical Innovations Group Plc logo

Surgical Innovations Group Plc(LSE) SUN

Market Cap£4.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)-99%
5 Year-81%
1 Year-29%
1 Month+5%
£0.00
-2.17%
-0.00Today
Surgical Innovations Group Plc last closing stock price
MetricPriceDate
Last closeGBX 0.502026-07-30
Surgical Innovations Group Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%GBX 0.502026-07-23
1 month+5.26%GBX 0.482026-06-30
3 month+11.11%GBX 0.452026-05-01
Year to date+11.11%GBX 0.452025-12-31
1 year-28.57%GBX 0.702025-07-30
3 year-70.59%GBX 1.702023-07-31
5 year-81.48%GBX 2.702021-07-30
Since inception-99.35%GBX 0.771992-01-02

Surgical Innovations Group Plc Financials at a Glance

Market Cap

£4.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£23.55M

Net Income (TTM)

-£2.84M

EPS (TTM)

-£0.00

P/E Ratio

-5.00

Dividend

£0.00

Beta (Volatility)

0.07 (Low)

Price

£0.00

Volume

7,448

Open

£0.01

Previous Close

£0.00

Daily Range

£0.00 - £0.00

52-Week Range

£0.00 - £0.01

Estimated Earnings Date

Sep 16, 2026

SUN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Surgical Innovations Group Plc

Surgical Innovations Group plc is an international company specializing in the design, development, manufacturing, and marketing of devices for minimally invasive surgery. Established in 1988 and headquartered in Leeds, the company operates across various global markets, including the UK, Europe, Asia Pacific, and the United States.

Products and Services
  • SI-branded minimally invasive instruments, including YelloPort Elite and LogiRange systems
  • OEM services for third-party medical device firms
  • Distribution of medical products through Elemental Healthcare Ltd
Growth Outlook
  • Recent quarterly revenue of £5.46 million shows potential for recovery
  • Gross profit margin improved to 20.7% in Q4 2025
  • Expansion into new markets is anticipated to drive future growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of £22.5 million indicates stable performance
  • Operating cash flow of £808,000 in Q4 2025 reflects operational efficiency
  • Current ratio of 1.48 suggests strong short-term financial health
Surgical Innovations Group plc operates through three divisions: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The SI Brand segment focuses on proprietary instruments for minimally invasive surgery, while the OEM division provides tailored solutions for third-party firms. The Distribution segment supplies various medical products, enhancing the company's market reach. The growth outlook appears promising, with recent revenue figures indicating a potential recovery trajectory. The improvement in gross profit margin suggests better cost management and operational efficiency. Additionally, the company's strategic expansion into new markets may further bolster its growth prospects. Financially, the company has demonstrated resilience, with a trailing twelve months revenue of £22.5 million. The positive operating cash flow in the most recent quarter indicates effective management of resources. Furthermore, a current ratio of 1.48 highlights the company's ability to meet short-term obligations, reflecting a solid financial foundation. Overall, Surgical Innovations Group plc presents an intriguing opportunity for investors interested in the medical devices sector, particularly in the minimally invasive surgery market.
AI Generated • Jul 28, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

David John Marsh

Website

sigroupplc.com

Headquarters

Leeds, YO LS16 6QZ, GB

SUN Financials

Key Financial Metrics (TTM)

Gross Margin

26.31%

Operating Margin

-6.27%

Net Income Margin

-7.71%

Return on Equity

-11.04%

Return on Capital

-8.80%

Return on Assets

-7.69%

Earnings Yield

-20.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£4.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

932.82M

Volume

7.45K

Avg. Volume

158.38K

Financials (TTM)

Gross Profit

£6.49M

Operating Income

-£1.37M

EBITDA

-£1.33M

Operating Cash Flow

£495.00K

Capital Expenditure

-£128.00K

Free Cash Flow

£367.00K

Cash & ST Invst.

£813.00K

Total Debt

£665.00K

Surgical Innovations Group Plc Performance Analysis

Surgical Innovations Group Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 11,340,00024.3%
20232023-12-31GBP 12,014,0005.9%
20242024-12-31GBP 11,945,000-0.6%
20252025-12-31GBP 11,602,000-2.9%
Surgical Innovations Group Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-3.0%
Q42024-12-31-6.6%
Q22025-06-306.5%
Q42025-12-31-11.2%
Surgical Innovations Group Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP 0.00N/A
20232023-12-31GBP -0.00N/A
20242024-12-31GBP -0.00250.0%
20252025-12-31GBP -0.00-52.4%
Surgical Innovations Group Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-400.0%
Q42024-12-31-220.0%
Q22025-06-30100.0%
Q42025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£5.46M

-14.3%

Gross Profit

£1.13M

-21.7%

Gross Margin

20.74%

N/A

Market Cap

£4.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£56.88K

N/A

Employees

82

N/A

Net Income

-£916.00K

-578.5%

EBITDA

-£443.00K

-561.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£813.00K

-32.9%

Total Debt

£665.00K

-60.0%

Accounts Receivable

£1.75M

N/A

Inventory

£2.19M

-23.2%

Long Term Debt

£291.00K

-72.3%

Short Term Debt

£374.00K

-38.8%

Return on Assets

-7.69%

N/A

Return on Invested Capital

-8.87%

N/A

Free Cash Flow

£772.00K

+498.4%

Operating Cash Flow

£808.00K

+57.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TCF.LTheracryf Plc
£0.00+0.00%
CNSL.LCambridge Nutritional Sciences plc
£0.02+0.00%
TRX.LTissue Regenix Group plc
£0.07+0.00%
PRM.LProteome Sciences plc
£0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.13+0.11%
NVDANvidia
$195.04+0.03%
MSFTMicrosoft
$451.10+0.16%
NOKNokia
$9.09+0.08%

Questions About SUN

What is the current price of Surgical Innovations Group Plc?

Surgical Innovations Group Plc is trading at £0.00 per share.

What is the 52-week range for Surgical Innovations Group Plc?

Over the past 52 weeks, Surgical Innovations Group Plc has traded between £0.00 and £0.01.

How much debt does Surgical Innovations Group Plc have?

As of the most recent reporting period, Surgical Innovations Group Plc reported total debt of £665.00K.

How much cash does Surgical Innovations Group Plc have on hand?

Surgical Innovations Group Plc reported £813.00K in cash and cash equivalents in its most recent financial results.

What is Surgical Innovations Group Plc’s dividend yield?

Surgical Innovations Group Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services